Genomic Health (GHDX) Highlights New Data Reinforcing Positive Impact of Oncotype DX Genomic Prostate Score

May 21, 2018 8:11 AM

Genomic Health, Inc. (NASDAQ: GHDX) today announced results from two new studies demonstrating the positive impact of the Oncotype DX® ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found